TuHURA Biosciences, Inc. ( HURA) - Key Metrics
HURA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.14 | -$0.13 | -$0.14 |
| 2026Q1 | $0 | -$0.13 | -$0.07 | -$0.07 |
| 2025Q4 | $0 | -$0.14 | -$0.12 | -$0.12 |
| 2025Q3 | $0 | -$0.14 | -$0.22 | -$0.22 |
| 2025Q2 | $0 | -$0.21 | -$0.14 | -$0.14 |
HURA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -0.02% | -4.18 |
| 2026Q1 | -0.03% | -3.44 |
| 2025Q4 | -0.03% | -1.46 |
| 2025Q3 | -0.03% | -4.43 |
| 2025Q2 | -0.02% | -2.65 |
HURA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -5.86% | 0.00% |
| 2026Q1 | -4.15% | 0.00% |
| 2025Q4 | -15.40% | 0.01% |
| 2025Q3 | -8.82% | 0.00% |
| 2025Q2 | -6.29% | 0.00% |
HURA
Price: $2
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 145.3 million